Elevated Neutrophil-to-Lymphocyte Ratio Is Associated With Poor Outcomes for Melanoma Patients Treated With PD-1 Inhibitor or Chemotherapy in a Chinese Population
Background: Previous studies have suggested that an elevated pre-treatment neutrophil-to-lymphocyte ratio (NLR) is associated with worse outcomes in patients with a variety of cancers. The purpose of this retrospective analysis is to investigate the prognostic value of the NLR in a Chinese melanoma...
Main Authors: | Yalong Qi, Daixiang Liao, Dinglian Mei, Yong Zhang, Yang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01752/full |
Similar Items
-
Elevated neutrophil to lymphocyte ratio predicts poor prognosis in patients with non-small cell lung cancer after surgery
by: Xiaojun Ju, et al.
Published: (2020-09-01) -
Neutrophil to lymphocyte ratio in immunotherapy for malignancies
by: Bassim Kobrossy
Published: (2020-01-01) -
The Neutrophil to Lymphocyte Ratio May Predict Benefit from Chemotherapy in Lung Cancer
by: Dan Liu, et al.
Published: (2018-04-01) -
The ratio of neutrophil to lymphocyte is a predictor in endometrial cancer
by: Dong Yangyang, et al.
Published: (2019-04-01) -
Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
by: Huan Wang, et al.
Published: (2020-06-01)